Samuel Hintermann

1.5k citations

28 papers · 1.1k indexed · h-index 19

Impact in

Cellular and Molecular Neuroscience top 5%
- Neuroscience and Neuropharmacology Research
Endocrine and Autonomic Systems top 5%
- Circadian rhythm and melatonin

Papers in ⓘ

Cellular and Molecular Neuroscience 9
- Neuroscience and Neuropharmacology Research 5
- Nuclear Receptors and Signaling 4
Endocrine and Autonomic Systems 3

Co-authors: Yves P. Auberson (3 shared papers)F. Gasparini (3 shared papers)Simon M. Ametamey (3 shared papers)Matthias T. Wyss (2 shared papers)Alfred Buck (2 shared papers)Samuel J. Danishefsky (3 shared papers)Peter W. Glunz (3 shared papers)Kenneth O. Lloyd (3 shared papers)
Journals: Bioorganic & Medicinal Chemistry Letters (3 papers)Journal of the American Chemical Society (2 papers)Frontiers in Neuroscience (2 papers)ChemMedChem (2 papers)Journal of Medicinal Chemistry (2 papers)
Partner nations: Switzerland United States Germany

In The Last Decade

Samuel Hintermann

28 papers receiving 1.1k citations

Peers

Countries citing papers authored by Samuel Hintermann

Since Specialization

Citations

This map shows the geographic impact of Samuel Hintermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel Hintermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel Hintermann more than expected).

Fields of papers citing papers by Samuel Hintermann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samuel Hintermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel Hintermann. The network helps show where Samuel Hintermann may publish in the future.

Co-authors

The 25 scholars most cited alongside Samuel Hintermann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Samuel Hintermann Line = papers co-authored together Samuel Hintermann links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Radiosynthesis and preclinical evaluation of 11C-ABP688 as a probe for imaging the metabotropic glutamate receptor subtype 5. PubMed ·Simon M. Ametamey, Lea J. Kessler, Michael Honer, Matthias T. Wyss, Alfred Buck, Samuel Hintermann, Yves P. Auberson, F. Gasparini, P. August Schubiger	2006	150
2	Human PET studies of metabotropic glutamate receptor subtype 5 with 11C-ABP688. PubMed ·Simon M. Ametamey, Valérie Treyer, Johannes Streffer, Matthias T. Wyss, Mark E. Schmidt, M. Blagoev, Samuel Hintermann, Yves P. Auberson, F. Gasparini, Uta C. Fischer, Alfred Buck	2007	136
3	Toward optimized carbohydrate-based anticancer vaccines: Epitope clustering, carrier structure, and adjuvant all influence antibody responses to Lewis^yconjugates in mice Proceedings of the National Academy of Sciences ·Valery Kudryashov, Peter W. Glunz, Lawrence J. Williams, Samuel Hintermann, Samuel J. Danishefsky, Kenneth O. Lloyd	2001	90
4	Identification of a Novel Series of Orexin Receptor Antagonists with a Distinct Effect on Sleep Architecture for the Treatment of Insomnia Journal of Medicinal Chemistry ·Claudia Betschart, Samuel Hintermann, Dirk Behnke, Simona Cotesta, Markus Fendt, Christine E. Gee, Laura H. Jacobson, Grit Laue, Silvio Ofner, Vinod D. Chaudhari, Sangamesh Badiger, Chetan Pandit, Juergen Wagner, Daniël Hoyer	2013	86
5	ABP688, a novel selective and high affinity ligand for the labeling of mGlu5 receptors: Identification, in vitro pharmacology, pharmacokinetic and biodistribution studies Bioorganic & Medicinal Chemistry ·Samuel Hintermann, Ivo Vranesic, Hans Allgeier, Armin Brülisauer, Daniël Hoyer, Michel Lemaire, Thomas Moenius, Stephan Urwyler, Steven Whitebread, F. Gasparini, Yves P. Auberson	2006	55
6	Design and Synthesis of Le^y-Bearing Glycopeptides that Mimic Cell Surface Le^yMucin Glycoprotein Architecture Journal of the American Chemical Society ·Peter W. Glunz, Samuel Hintermann, Lawrence J. Williams, Jacob B. Schwarz, Scott D. Kuduk, Valery Kudryashov, Kenneth O. Lloyd, Samuel J. Danishefsky	2000	55
7	Structural States of RORγt: X‐ray Elucidation of Molecular Mechanisms and Binding Interactions for Natural and Synthetic Compounds ChemMedChem ·Joerg Kallen, Aude Izaac, C. Be, Luca Arista, David Orain, Klemens Kaupmann, Christine Guntermann, Klemens Hoegenauer, Samuel Hintermann	2017	49
8	Pharmacological inhibition of RORγt suppresses the Th17 pathway and alleviates arthritis in vivo PLoS ONE ·Ulf Guendisch, Jessica Weiss, Florence Ecoeur, Julia Riker, Klemens Kaupmann, Joerg Kallen, Samuel Hintermann, David Orain, Janet Dawson, Andreas Billich, Christine Guntermann	2017	46
9	Retinoic-acid-orphan-receptor-C inhibition suppresses Th17 cells and induces thymic aberrations JCI Insight ·Christine Guntermann, Alessandro Piaia, Marie-Laure Hamel, Diethilde Theil, Tina Rubic-Schneider, Alberto Del Río-Espínola, Linda M. Dong, Andreas Billich, Klemens Kaupmann, Janet Dawson, Klemens Hoegenauer, David Orain, Samuel Hintermann, Rowan Stringer, Dhavalkumar D. Patel, Arno Doelemeyer, Mark Deurinck, Jens Schümann	2017	41
10	Identification of a series of highly potent activators of the Nurr1 signaling pathway Bioorganic & Medicinal Chemistry Letters ·Samuel Hintermann, Michele Chiesi, Ulrike von Krosigk, Danièle Mathé, Richard Felber, Bastian Hengerer	2006	38
11	Distinct effects of IPSU and suvorexant on mouse sleep architecture Frontiers in Neuroscience ·Daniël Hoyer, Thomas Dürst, Markus Fendt, Laura H. Jacobson, Claudia Betschart, Samuel Hintermann, Dirk Behnke, Simona Cotesta, Grit Laue, Silvio Ofner, Eric Legangneux, Christine E. Gee	2013	35
12	Effects of Isoxazolo-Pyridinone 7e, a Potent Activator of the Nurr1 Signaling Pathway, on Experimental Autoimmune Encephalomyelitis in Mice PLoS ONE ·Francesca Montarolo, Chiara Raffaele, Simona Perga, Serena Martire, Annamaria Finardi, Roberto Furlan, Samuel Hintermann, Antonio Bertolotto	2014	35
13	Electron transfer reactions involving trans-[PtH2(PCy3)2] and fluorinated benzonitriles Journal of Organometallic Chemistry ·Samuel Hintermann, Paul S. Pregosin, Heinz Rüegger, H. C. Clark	1992	35
14	Kinetic properties of “dual” orexin receptor antagonists at OX1R and OX2R orexin receptors Frontiers in Neuroscience ·Gabrielle E. Callander, Morenike Olorunda, Dominique Monna, Edi Schuepbach, Daniel Langenegger, Claudia Betschart, Samuel Hintermann, Dirk Behnke, Simona Cotesta, Markus Fendt, Grit Laue, Silvio Ofner, Emmanuelle Briard, Christine E. Gee, Laura H. Jacobson, Daniël Hoyer	2013	33
15	Antagonizing Retinoic Acid-Related-Orphan Receptor Gamma Activity Blocks the T Helper 17/Interleukin-17 Pathway Leading to Attenuated Pro-inflammatory Human Keratinocyte and Skin Responses Frontiers in Immunology ·Florence Ecoeur, Jessica Weiss, Klemens Kaupmann, Samuel Hintermann, David Orain, Christine Guntermann	2019	29
16	Anti-Parkinsonian Effects of Nurr1 Activator in Ubiquitin-Proteasome System Impairment Induced Animal Model of Parkinson’s Disease CNS & Neurological Disorders - Drug Targets ·Zhen Zhang, Xuping Li, Wenjie Xie, Houzhen Tuo, Samuel Hintermann, Joseph Jankovic, Weidong Le	2012	26
17	Comparison of [18F]FDOPA, [18F]FMT and [18F]FECNT for imaging dopaminergic neurotransmission in mice Nuclear Medicine and Biology ·Michael Honer, Bastian Hengerer, M. Blagoev, Samuel Hintermann, P. C. Waldmeier, P. August Schubiger, Simon M. Ametamey	2006	25
18	Probing Cell Surface “Glyco-Architecture” through Total Synthesis. Immunological Consequences of a Human Blood Group Determinant in a Clustered Mucin-like Context Journal of the American Chemical Society ·Peter W. Glunz, Samuel Hintermann, Jacob B. Schwarz, Scott D. Kuduk, Xiaotao Chen, Lawrence J. Williams, Dalibor Sameš, Samuel J. Danishefsky, Valery Kudryashov, Kenneth O. Lloyd	1999	25
19	Synthesis and Biological Evaluation of New Triazolo‐ and Imidazolopyridine RORγt Inverse Agonists ChemMedChem ·Samuel Hintermann, Christine Guntermann, Henri Mattes, David A. Carcache, Juergen Wagner, Anna Vulpetti, Andreas Billich, Janet Dawson, Klemens Kaupmann, Joerg Kallen, Rowan Stringer, David Orain	2016	20
20	Optimizing a Weakly Binding Fragment into a Potent RORγt Inverse Agonist with Efficacy in an in Vivo Inflammation Model Journal of Medicinal Chemistry ·David A. Carcache, Anna Vulpetti, Joerg Kallen, Henri Mattes, David Orain, Rowan Stringer, Eric Vangrevelinghe, Romain M. Wolf, Klemens Kaupmann, Johannes Ottl, Janet Dawson, Nigel G. Cooke, Klemens Hoegenauer, Andreas Billich, Juergen Wagner, Christine Guntermann, Samuel Hintermann	2018	18

About Samuel Hintermann

Samuel Hintermann is a scholar working on Cellular and Molecular Neuroscience, Endocrine and Autonomic Systems, Experimental and Cognitive Psychology, Immunology and Organic Chemistry, having authored 28 papers that have together received 1.1k indexed citations. Recurring topics across this work include Chemical Synthesis and Analysis (5 papers), Sleep and related disorders (5 papers), Sleep and Wakefulness Research (5 papers), Neuroscience and Neuropharmacology Research (5 papers), Nuclear Receptors and Signaling (4 papers), IL-33, ST2, and ILC Pathways (4 papers), Psoriasis: Treatment and Pathogenesis (4 papers) and Glycosylation and Glycoproteins Research (3 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (384 citations), Endocrine and Autonomic Systems (109 citations), Immunology (216 citations), Biological Psychiatry (24 citations) and Experimental and Cognitive Psychology (115 citations). Samuel Hintermann has collaborated with scholars based in Switzerland, United States and Germany. Frequent co-authors include Yves P. Auberson, F. Gasparini, Simon M. Ametamey, Matthias T. Wyss, Alfred Buck, Samuel J. Danishefsky, Peter W. Glunz, Kenneth O. Lloyd, Lawrence J. Williams and Valery Kudryashov. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of the American Chemical Society, Frontiers in Neuroscience, ChemMedChem and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact